Copernicus services supports Global Pharmaceuticals
Asthma is a condition which impacts the daily lives of 30 million Europeans and 300 million people globally. People with asthma may experience coughing, wheezing and trouble breathing among other ailments. According to the European Federation of Asthma and Allergy Associations, the global asthma prevalence could increase to 400 million people worldwide by 2025. A…
Read more
